NPM1 and acute myeloid leukemia: Several recent studies have evaluated the use of dPCR for MRD monitoring in AML, particularly for NPM1 mutations, for which dPCR has shown good correlation with qPCR-MRD [103], even for rare mutation types [63], and has also been shown to be a predictive factor for relapse in AML [104].